Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Pfizer selects GH secretagogue as development candidate

Sep. 8, 1998

Lilly's mGlu agonists exert neuroprotective effects in vivo

Sep. 8, 1998

Novel lipid-lowering agent presented by Wayne Hughes Institute at scientific forum

Sep. 8, 1998

Novel actions of statins reported at the 20th Congress of the European Society of Cardiology

Sep. 8, 1998

Efficacy and safety of sublingual apomorphine in treatment of MED

Sep. 7, 1998

Invicorp trial results highlighted at recent congress

Sep. 7, 1998

DMP-695: ACS debut for new, orally active CRF1 antagonist

Sep. 7, 1998

Potent, orally active, second-generation neuroimmunophilin from Guilford

Sep. 7, 1998

Candidate oral fibrinogen receptor antagonist presented by Uriach at ACS meeting

Sep. 7, 1998

Isoxazoline- and isoxazole-containing factor Xa inhibitors prepared by DuPont

Sep. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...